FIGS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Figs Inc (FIGS) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company has shown strong financial growth, positive analyst sentiment, and a favorable long-term outlook. Despite short-term technical weakness and insider selling, the stock's potential for international expansion, product innovation, and operational recovery make it a compelling long-term investment.
The MACD is negative and contracting, indicating bearish momentum. RSI is neutral at 59.327, showing no clear overbought or oversold condition. Moving averages are converging, suggesting indecision in price action. Key support is at 14.078, and resistance is at 15.72. The stock is trading slightly below its pivot point of 14.899, reflecting short-term weakness.
Strong financial performance in Q4 2025 with revenue up 32.97% YoY and net income up 881.80% YoY.
Analysts have upgraded the stock with higher price targets, citing operational recovery, international expansion, and product innovation.
SwingMax entry signal on 2026-03-24 indicates potential for short-term gains.
Positive stock trend analysis suggests a 7.65% potential gain in the next month.
Insiders are selling, with a significant 1848.51% increase in selling activity over the last month.
Gross margin dropped by 6.49% YoY in Q4 2025, indicating some cost pressures.
The stock is down 2.59% in the regular market and 0.19% post-market, reflecting short-term bearish sentiment.
In Q4 2025, Figs reported revenue growth of 32.97% YoY to $201.9 million. Net income surged by 881.80% YoY to $18.5 million, and EPS increased by 900% YoY to $0.10. However, gross margin declined by 6.49% YoY to 62.94%. Overall, the company demonstrated strong profitability and revenue growth despite some margin compression.
Analysts are highly optimistic about Figs, with multiple upgrades and price target increases. Oppenheimer upgraded the stock to Outperform with a $22 price target, citing operational recovery and long-term growth potential. Other firms like BTIG, KeyBanc, and Barclays have also raised their price targets, highlighting international expansion, product innovation, and strong sales momentum.
